Wiestler, B., Capper, D., Platten, M., Pfister, S., Deimling, A. v., & Wick, W. (2014). Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology, 16(12), . https://doi.org/10.1093/neuonc/nou138
Chicago-Zitierstil (17. Ausg.)Wiestler, Benedikt, David Capper, Michael Platten, Stefan Pfister, Andreas von Deimling, und Wolfgang Wick. "Assessing CpG Island Methylator Phenotype, 1p/19q Codeletion, and MGMT Promoter Methylation from Epigenome-wide Data in the Biomarker Cohort of the NOA-04 Trial." Neuro-Oncology 16, no. 12 (2014). https://doi.org/10.1093/neuonc/nou138.
MLA-Zitierstil (9. Ausg.)Wiestler, Benedikt, et al. "Assessing CpG Island Methylator Phenotype, 1p/19q Codeletion, and MGMT Promoter Methylation from Epigenome-wide Data in the Biomarker Cohort of the NOA-04 Trial." Neuro-Oncology, vol. 16, no. 12, 2014, https://doi.org/10.1093/neuonc/nou138.